Screening Protocol for HIV Vaccine Studies

CompletedOBSERVATIONAL

Enrollment

1,324

Participants

Timeline

Start Date

February 27, 2002

Study Completion Date

April 8, 2013

Conditions

HIV SeronegativityHIV Infections

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00031304 - Screening Protocol for HIV Vaccine Studies | Biotech Hunter | Biotech Hunter